Trial Profile
A Randomized, Double-Blinded, Placebo Controlled Trial Using Single Dose Dexmedetomidine In The Treatment Of Pain In Patients Undergoing Cleft Palate Repair
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 22 Aug 2021
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 04 Feb 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
- 04 Feb 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2019.
- 04 Feb 2019 Planned initiation date changed from 1 Dec 2016 to 31 Dec 2017.